Glaukos (GKOS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Glaukos Corp  (NYSE: GKOS)
 

Glaukos Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Glaukos Corp inventory turnover ratio, the Glaukos Corp's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.06 in the second quarter 2026, yet the ratio remained below the average, as GKOS's market remain challenging.Average inventory processing period, for the Glaukos in Jun 30 2026 quarter, has decreased to 177 days, compare to 193 days, in the Mar 31 2026 quarter.

Within Healthcare sector 192 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1595, from total ranking in the first quarter 2026 at 1775.

GKOS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Glaukos Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GKOS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -8.22 % 4.92 % 10.2 % 6.62 % 14.41 %
Y / Y Cost of Sales Growth 30.83 % 37.5 % 10 % 27.27 % 18.18 %
Inventory Turnover Ratio (TTM) 2.06 1.89 1.77 1.76 1.69
GKOS's Total Ranking # 1595 # 1775 # 1686 # 1705 # 1712
Average inventory processing period 178 193 207 208 216
Seq. Inventory Growth -4.93 % -1.86 % -0.47 % -1.17 % 8.68 %
Seq. Cost of Sales Growth 3.08 % 0 % 17.86 % 7.69 % 8.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 81
Healthcare Sector # 193
Overall Market # 1595

Inventory Turnover Ratio Statistics
High Average Low
4.34 2.5 1.59
(Dec 31 2020)   (Sep 30 2024)



GKOS Company Profile >> Back to GKOS Efficiency Comparisons >> Compare GKOS Inventory Turnover Ratio to its Competitors

Financial Statements
Glaukos's Inventories $ 59 Millions Visit GKOS's Balance sheet
Glaukos's Cost of Revenues TTM $ 128 Millions Visit GKOS's Income Statement
What are GKOS's Sales? Visit GKOS's Sales by Segment

Other Inventory Turnover Ratios
Glaukos's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GKOS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GKOS's Competitors
Inventory Turnover Ratio for GKOS's Suppliers
Inventory Turnover Ratio for GKOS's Customers

You may also want to know
GKOS's Sales Growth Rates GKOS's Pe Price to earnings ratio GKOS's Receivables Turnover Ratio GKOS's Stock Quote
GKOS's Net Income Growth Rates GKOS's Ps Price to Sales ratio GKOS's Sales per Employee GKOS's Asset Turnover Ratio
GKOS's Net Margin GKOS's Pb Price to Book ratio GKOS's Financial Strength Ratios GKOS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions

Date modified: 2026-08-13T08:43:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.